VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 34 | -39.3% | 0.00% | – |
| Q4 2017 | $1,000 | – | 56 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 56 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 56 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 56 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -100.0% | 56 | -99.8% | 0.00% | -100.0% |
| Q3 2015 | $5,708,000 | -33.3% | 32,000 | -16.9% | 0.04% | -26.0% |
| Q2 2015 | $8,552,000 | -14.7% | 38,500 | -23.8% | 0.05% | -13.8% |
| Q1 2015 | $10,030,000 | +15.8% | 50,500 | -16.5% | 0.06% | +18.4% |
| Q4 2014 | $8,658,000 | -29.0% | 60,500 | -34.9% | 0.05% | -31.0% |
| Q3 2014 | $12,188,000 | -57.7% | 92,900 | -59.3% | 0.07% | -61.0% |
| Q2 2014 | $28,780,000 | +67.3% | 228,200 | +74.9% | 0.18% | +61.1% |
| Q1 2014 | $17,203,000 | -30.9% | 130,500 | -38.5% | 0.11% | -31.5% |
| Q4 2013 | $24,892,000 | – | 212,031 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |